Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation

Molecular Cancer Research

Volumn 1, Issue 8, 2003, Pages 598-609

  Schwarz, Julie K ^a   Lovly, Christine M ^a   Piwnica Worms, Helen ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; ISOLEUCINE; PROTEIN SERINE THREONINE KINASE; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOPHOSPHORYLATION; CATALYSIS; CIS TRANS ISOMERISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FAMILIAL CANCER; FIBROBLAST; HUMAN; HUMAN CELL; IONIZING RADIATION; MUTATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

BACTERIA; CATALYTIC DOMAIN; ENZYME ACTIVATION; GENETIC COMPLEMENTATION TEST; HELA CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SERINE; THREONINE;

MURINAE;

EID: 0037795780     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Elledge. S. J. Cell cycle checkpoints: preventing an identity crisis. Science, 274: 1664-1672, 1996.
2. Bentley, N. J., Hawkins, G., Keegan, K., DeMaggio, A., Holtzman, D., Ford, J. C., Hoekstra, M., and Carr, A. M. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J., 15: 6641-6651, 1996.
3. Cimprich, K. A., Shin, T. B., Keith, C. T., and Schreiber, S. L. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA, 93: 2850-2855, 1996.
4. Shiloh, Y. Ataxia-telangiectasia and Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet., 31: 635-662, 1997.
5. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia Telangiectasia. Cell, 71: 587-597, 1992.
6. Blasina, A., Van de Weyer, I., Laus, M. C., Luyten, W. H. M. L., Parker, A. E., and McGowan, C. H. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr. Biol., 9: 1-10, 1998.
7. Brown, A., Lee, C-H., Schwarz, J. K., Mitiku, N., Griffith, D., Piwnica-Worms, H., and Chung, J. H. A human Cds1-related kinase that functions downstream of ATM in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA, 96: 3745-3750, 1999.
8. Chaturvedi, P., Eng, W. K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., Scott, G. F., Li, X., Carr, S. A., Johnson, R. K., Winkler, J. D., and Zhou, B-B. S. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene, 18: 4047-4054, 1999.
9. Matsuoka, S., Huang, M., and Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 282: 1893-1897, 1998.
10. Chehab, N. H., Malikzay, A., Appel, M., and Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev., 14: 278-288, 2000.
11. Takai, H., Naka, K., Okada, Y., Watanabe, M., Harada, N., Saito, S., Anderson, C. W., Appella, E., Nakanishi, M., Suzuki, H., Nagashima, K., Sawa, H., Ikeda, K., and Motoyama, N. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J., 21: 5195-5205, 2002.
12. Hirao, A., Cheung, A., Duncan, G., Girard, P. M., Elia, A. J., Wakeham, A., Okada, H., Sarkissian, T., Wong, J. A., Sakai, T., De Stanchina, E., Bristow, R. G., Suda, T., Lowe, S. W., Jeggo, P. A., Elledge, S. J., and Mak, T. W. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol., 22: 6521-6532, 2002.
13. Bell, D. W., Variey, J. M., Szydlo, T. E., Kang, D. H., Wahrer-Doke, C. R., Shannon, K. E., Lubratovich, M., Versellls, S. J., Isselbacher, K. J., Fraumeni, J. F., Birch, J. M., Li, F. P., Garber, J. E., and Haber, D. A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni Syndrome. Science, 286: 2528-2531, 1999.
14. Ahn, J-Y., Schwarz, J. K., Piwnica-Worms, H., and Canman, C. E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res., 60: 5934-5936, 2000.
15. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tarnai, K., and Elledge, S. J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA, 97: 10389-10394, 2000.
16. Melchionna, R., Chen, X. B., Blasina, A., and McGowan, C. H. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol., 2: 762-765, 2000.
17. Zhou, B. B., Chaturvedi, P., Spring, K., Scott, S. P., Johanson, R. A., Mishra, R., Mattern, M. R., Winkler, J. D., and Khanna, K. K. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem., 275: 10342-10348, 2000.
18. Lee, C-H. and Chung, J. H. The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation. J. Biol. Chem., 276: 30537-30541, 2001.
19. Durocher, D., Henckel, J., Fersht, A. R., and Jackson, S. P. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell, 4: 387-394, 1999.
20. Durocher, D., Taylor, I. A., Sarbassova, D., Haire, L. F., Westcott, S. L., Jackson, S. P., Smerdon, S. J., and Yaffe, S. P. The molecular basis of FHA domain: phosphopeptide binding specificity and implications for phosph-dependent signaling mechanisms. Mol. Cell, 6, 1169-1182, 2000.
21. Li, J., Williams, B. L., Haire, L. F., Goldberg, M., Wilker, E., Durocher, D., Yaffe, M. B., Jackson, S. P., and Smerdon, S. J. Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol. Cell, 9: 1045-1054, 2002.
22. Ahn, J-Y., Li, X., Davis, H. L., and Canman, C. E. Phosphorylation of Threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated (FHA) domain. J. Biol. Chem., 277: 19389-19395, 2002.
23. Xu, X., Tsvetkov, L. M., and Stern, D. F. Chk2 activation and phosphorylation-dependent oligomerization. Mol. Cell. Biol., 22: 4419-4432, 2002.
24. Gilbert, C. S., Green, C. M., and Lowndes, N. F. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell, 8: 129-136, 2001.
25. Ziv, Y., Bar-Shira, A., Pecker, I., Russell, P., Jorgensen, T., Tsarfati, I., and Shiloh, Y. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene, 15: 159-167, 1997.
26. Wu, X., Webster, S. R., and Chen, J. Characterization of tumor-associated Chk2 mutations. J. Biol. Chem., 276: 2971-2974, 2001.
27. Ward, I. M., Wu, X., and Chen, J. Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J. Biol. Chem., 276: 47755-47758, 2001.
28. Lukas, C., Falck, J., Bartkova, J., Bartek, J., and Lukas, J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol., 5: 255-260, 2003.
29. Tsvetkov, L. M., Xu, X., Li, J., and Stem, D. F. Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J. Biol. Chem., 278: 8468-8475, 2003.
30. Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., and Piwnica-Worms, H. The Chk1 protein kinase and the Cdc25C regulatory pathway are targets of the anticancer agent UCN-01. J. Biol. Chem., 275: 5600-5605, 2000.
31. van der Geer, P. and Hunter, T. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis, 15: 544-554, 1994.
32. Ogg, S., Gabrielli, B., and Piwnica-Worms, H. Purification ofa serine kinase that associates with and phosphorylates human Cdc25C on serine 216. J. Biol. Chem., 269: 30461-30469, 1994.
33. He, T-C., Zhou, S., DaCosta, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci., 95: 2509-2514, 1998.